These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 3176581

  • 1. [Body height in children with growth hormone deficiency: results following 5-l5 years of treatment].
    Tanner JM.
    Z Gesamte Inn Med; 1988 Aug 01; 43(15):408-11. PubMed ID: 3176581
    [Abstract] [Full Text] [Related]

  • 2. [Adult height of patients after long-term treatment of idiopathic growth hormone deficiency. (Czech Registry 1991-1998)].
    Zapletalová J, Lebl J, Janstová V, Kalvachová B, Novotná D, Philippiová O.
    Cas Lek Cesk; 2000 Aug 30; 139(17):529-32. PubMed ID: 11109285
    [Abstract] [Full Text] [Related]

  • 3. Final height and growth hormone secretion after completion of growth hormone therapy in patients with idiopathic growth hormone deficiency and with abnormalities of the hypothalamic-pituitary region.
    Hilczer M, Smyczynska J, Stawerska R, Lewinski A.
    Neuro Endocrinol Lett; 2005 Feb 30; 26(1):19-24. PubMed ID: 15726014
    [Abstract] [Full Text] [Related]

  • 4. Effect of long-term growth hormone therapy on bone age and pubertal maturation in boys with and without classic growth hormone deficiency.
    Zadik Z, Chalew S, Zung A, Landau H, Leiberman E, Koren R, Voet H, Hochberg Z, Kowarski AA.
    J Pediatr; 1994 Aug 30; 125(2):189-95. PubMed ID: 8040760
    [Abstract] [Full Text] [Related]

  • 5. Final height in Swedish children with idiopathic growth hormone deficiency enrolled in KIGS treated optimally with growth hormone.
    Westphal O, Lindberg A, Swedish KIGS National Board.
    Acta Paediatr; 2008 Dec 30; 97(12):1698-706. PubMed ID: 18976357
    [Abstract] [Full Text] [Related]

  • 6. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
    Zenaty D, Garel C, Limoni C, Czernichow P, Léger J.
    Clin Endocrinol (Oxf); 2003 May 30; 58(5):647-52. PubMed ID: 12699449
    [Abstract] [Full Text] [Related]

  • 7. Growth hormone deficiency after chemotherapy for acute lymphoblastic leukemia in children who have not received cranial radiation.
    Haddy TB, Mosher RB, Nunez SB, Reaman GH.
    Pediatr Blood Cancer; 2006 Feb 30; 46(2):258-61. PubMed ID: 16369923
    [Abstract] [Full Text] [Related]

  • 8. Growth hormone therapy for children born small for gestational age: height gain is less dose dependent over the long term than over the short term.
    de Zegher F, Hokken-Koelega A.
    Pediatrics; 2005 Apr 30; 115(4):e458-62. PubMed ID: 15805349
    [Abstract] [Full Text] [Related]

  • 9. The results of long-term growth hormone replacement therapy in Turkish children with growth hormone deficiency.
    Yordam N, Kandemir N, Alikaşifoğlu A.
    Turk J Pediatr; 1998 Apr 30; 40(1):55-60. PubMed ID: 9673529
    [Abstract] [Full Text] [Related]

  • 10. Final height in children with idiopathic growth hormone deficiency treated with a fixed dose of recombinant growth hormone.
    Rachmiel M, Rota V, Atenafu E, Daneman D, Hamilton J.
    Horm Res; 2007 Apr 30; 68(5):236-43. PubMed ID: 17396034
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intermittent treatment with human growth hormone (GH) in isolated GH deficiency and in multiple pituitary hormone deficiencies.
    Pertzelan A, Kauli R, Assa S, Greenberg D, Laron Z.
    Clin Endocrinol (Oxf); 1976 Jan 30; 5(1):15-24. PubMed ID: 1248156
    [Abstract] [Full Text] [Related]

  • 15. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
    Lagrou K, Xhrouet-Heinrichs D, Massa G, Vandeweghe M, Bourguignon JP, De Schepper J, de Zegher F, Ernould C, Heinrichs C, Malvaux P, Craen M.
    J Pediatr Endocrinol Metab; 2001 Jan 30; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
    [Abstract] [Full Text] [Related]

  • 16. An auxology-based growth hormone program: update on the Australian experience.
    Werther GA, Wang M, Cowell CT.
    J Pediatr Endocrinol Metab; 2003 May 30; 16 Suppl 3():613-8. PubMed ID: 12795362
    [Abstract] [Full Text] [Related]

  • 17. Prader-Labhart-Willi syndrome: auxological response to a conventional dose of growth hormone in patients with classical growth hormone deficiency.
    Schmidt H, Bechtold S, Schwarz HP.
    Eur J Med Res; 2000 Jul 19; 5(7):307-10. PubMed ID: 10903191
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone treatment in short normal children.
    Bernasconi S, Volta C, Street ME, Mazzardo G, Ferzetti A, Iughetti L, Ghizzoni L.
    J Pediatr Endocrinol Metab; 1996 Jun 19; 9 Suppl 3():339-43. PubMed ID: 8887179
    [Abstract] [Full Text] [Related]

  • 19. Experience in the hGH treatment of children with hypothalamo-hypophyseal insufficiency.
    Rybak M, Sołtysik-Wilk E, Pleti M, Stepniewski M, Sztefko K.
    Acta Med Pol; 1979 Jun 19; 20(4):331-8. PubMed ID: 546082
    [No Abstract] [Full Text] [Related]

  • 20. [Growth hormones today].
    Butenandt O.
    Geburtshilfe Frauenheilkd; 1994 May 19; 54(5):253-6. PubMed ID: 8050683
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.